NASDAQ 
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $568.11, up $40.33 or 7.64% --On pace for largest percent increase since Sept. 8, 2022, when it rose 18.85% --Snaps a two day losing streak --Down 5.12% month-to-date
We recently compiled a list of the 10 Jim Cramer Stocks with Huge Upside Potential. In this article,...
We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this...
We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to...
In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)...
The worst performing large-cap stocks last week: ARGENX, VRTX, SMMT, MMYT, REGN, RKT, BNTX, AFRM,...
In the past week, REGN stock has gone down by -7.17%, with a monthly decline of -1.64% and a quarterly plunge of -24.15%. The volatility ratio for the week is 4.28%, and the volatility levels ...
Regeneron Pharmaceuticals (NasdaqGS:REGN) recently reported earnings for Q1 2025 with a revenue drop...
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting...
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) shares, rose in value, with the stock price down by -5.07% to the previous day’s close as strong demand from buyers drove the stock to $532.50. Actively ...
